Key terms
About SIGA
SIGA Technologies, Inc. is a commercial-stage pharmaceutical company, which engages in the development and commercialization of solutions for serious unmet medical needs and biothreats. The firm develops therapeutic solutions for lethal pathogens including smallpox, Ebola, dengue, Lassa fever, and other dangerous viruses. It offers an orally administered antiviral drug that targets orthopoxviruses under the TPOXX brand. The company was founded by Steven Oliveira on December 28, 1995 and is headquartered in New York, NY.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest SIGA news
Apr 05
10:40am ET
Biotech Alert: Searches spiking for these stocks today
Apr 04
11:03am ET
Biotech Alert: Searches spiking for these stocks today
Apr 01
4:21pm ET
Siga amends promotional deal with Meridian to enhance Oral TPOXX growth
Mar 25
7:38am ET
Siga Technologies appoints Larry Miller as general counsel
Mar 15
11:32am ET
Biotech Alert: Searches spiking for these stocks today
Mar 14
11:01am ET
Biotech Alert: Searches spiking for these stocks today
Mar 12
5:34pm ET
Siga Technologies jumps 9% to $5.78 after Q4 results
Mar 12
5:34pm ET
Siga Technologies reports Q4 EPS $1.01 vs. (1c) last year
Mar 12
7:48am ET
Siga Technologies board declares special cash dividend of 60c per share
Jan 22
7:36am ET
Siga Technologies announces appointment of Nguyen as new CEO
No recent press releases are available for SIGA
SIGA Financials
Key terms
Ad Feedback
SIGA Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
SIGA Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range